heiBIB: Hillengaß, Jens

Hillengaß, Jens Dr. med.Universität HeidelbergHeidelberg

Publikationsliste einschränken

Publikationsjahre

Publikationstypen

Liste

Sprache

englisch (141)
deutsch (10)

Co-Autoren (Uni Heidelberg)

mehr ...

Co-Autoren (extern)

mehr ...

Publikationen in heiBIB

Bärtsch, Marc-Andrea: Carfilzomib, lenalidomide, and dexamethasone followed by salvage autologous stem cell transplant with or without maintenance for relapsed or refractory multiple myeloma / Marc-Andrea Baertsch, Mathilde Fougereau, Thomas Hielscher, Sandra Sauer, Iris Breitkreutz, Karin Jo… , 20 September 2021. - 13 S.
In: Cancers, ISSN 2072-6694. 13(2021), 18, special issue, Artikel-ID 4706, Seite 1-13
DOI: 10.3390/cancers13184706
Wennmann, Markus: Analyzing longitudinal wb-MRI data and clinical course in a cohort of former smoldering multiple myeloma patients : connections between MRI findings and clinical progression patterns / Markus Wennmann, Thomas Hielscher, Laurent Kintzelé, Bjoern H. Menze, Georg Langs, Maximilian Merz, … , 25 February 2021. - 16 S.
In: Cancers, ISSN 2072-6694. 13(2021), 5, Artikel-ID 961, Seite 1-16
DOI: 10.3390/cancers13050961
Bärtsch, Marc-Andrea: Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma / Marc-Andrea Baertsch, Elias K. Mai, Thomas Hielscher, Uta Bertsch, Hans J. Salwender, Markus Munder,… , 07 January 2021. - 10 S.
In: Blood cancer journal, ISSN 2044-5385. 11(2021), Artikel-ID 1, Seite 1-10
DOI: 10.1038/s41408-020-00390-3
Goldschmidt, Hartmut: Response-adapted lenalidomide maintenance in newly diagnosed myeloma : results from the phase III GMMG-MM5 trial / Hartmut Goldschmidt, Elias K. Mai, Jan Dürig, Christof Scheid, Katja C. Weisel, Christina Kunz, Uta … , 7 February 2020. - 13 S.
In: Leukemia, ISSN 1476-5551. 34(2020), 7, Seite 1853-1865
DOI: 10.1038/s41375-020-0724-1
Merz, Almuth: Serological response to vaccination after autologous transplantation for multiple myeloma is associated with improved progression-free and overall survival / Almuth M.A. Merz, Maximilian Merz, Yali Zhang, Kathryn Stecklein, Jordan Pleskow, George L. Chen, De… , 2021. - 8 S.
In: Transplantation and cellular therapy, ISSN 2666-6367. 27(2021), 3, Seite 245.e1-245.e8
DOI: 10.1016/j.jtct.2020.11.009
Spurny, Manuela: Changes in bone marrow at upon dietary-induced weight loss / Manuela Spurny, Yixin Jiang, Solomon A. Sowah, Ruth Schübel, Tobias Nonnenmacher, Robert Bertheau, R… , May 22, 2020. - 14 S.
In: Nutrients, ISSN 2072-6643. 12(2020,5) Artikel-Nummer 1509, 14 Seiten
DOI: 10.3390/nu12051509
Goldschmidt, Hartmut: Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma : the randomized GMMG phase III trial ReLApsE / Hartmut Goldschmidt, Marc-Andrea Baertsch, Jana Schlenzka, Natalia Becker, Christina Habermehl, Thom… , 21 July 2020. - 11 S.
In: Leukemia, ISSN 1476-5551. 35(2021), 4, Seite 1134-1144
DOI: 10.1038/s41375-020-0948-0
Blocka, Joanna: Response improvement rather than response status after first autologous stem cell transplantation is a significant prognostic factor for survival benefit from tandem compared with single transplantation in multiple myeloma patients / Joanna Blocka, Thomas Hielscher, Hartmut Goldschmidt, Jens Hillengass, 16 March 2020. - 8 S.
In: Biology of blood and marrow transplantation, ISSN 1523-6536. 26(2020), 7, Seite 1280-1287
DOI: 10.1016/j.bbmt.2020.03.006
Merz, Maximilian: Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma / Maximilian Merz, Thomas Hielscher, David Schult, Elias K. Mai, Marc S. Raab, Jens Hillengass, Anja S… , [2020]. - 5 S. : Diagramme
In: Leukemia, ISSN 1476-5551. 34(2020), 4, Seite 1192-1196
DOI: 10.1038/s41375-019-0634-2
Merz, Maximilian: Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma / Maximilian Merz, Thomas Hielscher, Elias Karl Mai, Anja Seckinger, Dirk Hose, Anna Jauch, Sandra Sau… , 27 August 2019. - 5 S.
In: Blood cancer journal, ISSN 2044-5385. 9(2019,9) Artikel-Nummer 71, 5 Seiten
DOI: 10.1038/s41408-019-0235-3
Sachpekidis, Christos: Quantitative dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography before autologous stem cell transplantation predicts survival in multiple myeloma : letters to the editor / Christos Sachpekidis, Maximilian Merz, Annette Kopp-Schneider, Anna Jauch, Marc-Steffen Raab, Sandra… , September 2019. - 4 S.
In: Haematologica, ISSN 1592-8721. 104(2019), 9, Seite e420-e423
DOI: 10.3324/haematol.2018.213041
Rasche, Leo: Lack of spleen signal on diffusion weighted MRI is associated with high tumor burden and poor prognosis in multiple myeloma / Leo Rasche, Manoj Kumar, Grant Gershner, Rohan Samant, Rudy Van Hemert, Anke Heidemeier, Constantin … , 2019. - 8 S.
In: Theranostics, ISSN 1838-7640. 9(2019), 16, Seite 4756-4763
DOI: 10.7150/thno.33289
Chan, E.: Alternative metrics for assessing clinical benefit with immunotherapy in oncology / E. Chan, C. Quinn, I. Hirji, J. Hillengass, K. Anderson, A. Oukessou, C. Davis, 2018
In: OncoImmunology, ISSN 2162-402X. 8(2019,10) Artikel-Nummer e1343774
DOI: 10.1080/2162402X.2017.1343774
Salwender, Hans: Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6 : a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma / Hans Salwender, Uta Bertsch, Katja Weisel, Jan Duerig, Christina Kunz, Axel Benner, Igor W. Blau, Ma… . -
London: BioMed Central, 2019. - 1 Online-Ressource (11 Seiten)
Mai, Elias K.: Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma / Elias K. Mai, Thomas Hielscher, Uta Bertsch, Jana Schlenzka, Hans J. Salwender, Markus Munder, Chris… , 2019. - 4 S.
In: Leukemia, ISSN 1476-5551. 33(2019), 1, Seite 258-261
DOI: 10.1038/s41375-018-0195-9
Salwender, Hans: Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6 : a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma / Hans Salwender, Uta Bertsch, Katja Weisel, Jan Duerig, Christina Kunz, Axel Benner, Igor W. Blau, Ma… , 28 May 2019. - 11 S.
In: BMC cancer, ISSN 1471-2407. 19(2019) Artikel-Nummer 504, 11 Seiten
DOI: 10.1186/s12885-019-5600-x
Hillengaß, Jens: International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders / Jens Hillengass, Saad Usmani, S Vincent Rajkumar, Brian G M Durie, María-Victoria Mateos, Sagar Loni… , 29 May 2019. - 11 S.
In: The lancet, ISSN 1474-5488. 20(2019), 6, Seite 302-312
DOI: 10.1016/S1470-2045(19)30309-2
Klein, André: Automatic bone segmentation in whole-body CT images / André Klein, Jan Warszawski, Jens Hillengaß, Klaus H. Maier-Hein, 2019. - 9 S.
In: International journal of computer assisted radiology and surgery, ISSN 1861-6429. 14(2019), 1, Seite 21-29
DOI: 10.1007/s11548-018-1883-7
Went, Molly: Author correction : identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma / Molly Went et al., 10 January 2019. - 3 S.
In: Nature Communications, ISSN 2041-1723. 10(2019) Artikel-Nummer 213, 3 Seiten
DOI: 10.1038/s41467-018-08107-8
Kriegsmann, Katharina: Cereblon-binding proteins expression levels correlate with hyperdiploidy in newly diagnosed multiple myeloma patients / Katharina Kriegsmann, Marc-Andrea Baertsch, Mohamed H. S. Awwad, Maximilian Merz, Dirk Hose, Anja Se… , 29 January 2019. - 10 S.
In: Blood cancer journal, ISSN 2044-5385. 9(2019), 2, Artikel-ID 13, Seite 1-10
DOI: 10.1038/s41408-019-0174-z
Maatouk, Imad: Patients with precursor disease exhibit similar psychological distress and mental HRQOL as patients with active myeloma / Imad Maatouk, Susanne He, Manuela Hummel, Stefan Hemmer, Michaela Hillengass, Hartmut Goldschmidt, M… , 21 January 2019. - 4 S.
In: Blood cancer journal, ISSN 2044-5385. 9(2019,2) Artikel-Nummer 9, 4 Seiten
DOI: 10.1038/s41408-019-0172-1
Seckinger, Anja: Treatment response and long-term survival in multiple myeloma in the GMMG-HD4 trial : neither profit all molecular entities alike, nor are remissions to different regimen equal / Anja Seckinger, Hans Jürgen Salwender, MD, Hans Martin, MD, Christof Scheid, Thomas Hielscher, Uta B… , 29 November 2018. - 4 S.
In: Blood, ISSN 1528-0020. 132(2018), Supplement_1, Artikel-ID 4485, Seite 1-4
DOI: 10.1182/blood-2018-99-113284
Awwad, Mohamed: The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma / Mohamed H.S. Awwad, Katharina Kriegsmann, Julian Plaumann, Michael Benn, Jens Hillengass, Marc S. Ra… , 01 Aug 2018. - 11 S.
In: OncoImmunology, ISSN 2162-402X. 7(2018), 10, Artikel-ID e1486356, Seite 1-11
DOI: 10.1080/2162402X.2018.1486356
Plaumann, Julian: IL-10 inducible CD8+ regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells / Julian Plaumann, Melanie Engelhardt, Mohamed H. S. Awwad, Hakim Echchannaoui, Eva Amman, Marc S. Raa… , 20 August 2018. - 13 S.
In: Cancer immunology immunotherapy, ISSN 1432-0851. 67(2018), 11, Seite 1695-1707
DOI: 10.1007/s00262-018-2230-0
Merz, Maximilian: Cytogenetic abnormalities in monoclonal gammopathy of undetermined significance / Maximilian Merz, Thomas Hielscher, Korbinian Hoffmann, Anja Seckinger, Dirk Hose, Marc S. Raab, Jens… , 6 July 2018. - 3 S.
In: Leukemia, ISSN 1476-5551. 32(2018), 12, Seite 2717-2719
DOI: 10.1038/s41375-018-0202-1
Went, Molly: Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology / Molly Went, Amit Sud, Helen Speedy, Nicola J. Sunter, Asta Försti, Philip J. Law, David C. Johnson, … , 2019. - 9 S.
In: Blood cancer journal, ISSN 2044-5385. 9(2019) Artikel-Nummer 1, 9 Seiten
DOI: 10.1038/s41408-018-0162-8
Bochtler, Tilmann: Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma / Tilmann Bochtler, Maximilian Merz, Thomas Hielscher, Martin Granzow, Korbinian Hoffmann, Alwin Kräme… , 2018. - 12 S.
In: Blood advances, ISSN 2473-9537. 2(2018), 20, Seite 2607-2618
DOI: 10.1182/bloodadvances.2018023200
Giesen, Nicola: Oncogene-induced senescence : a potential breakpoint mechanism against malignant transformation in plasma cell disorders / Nicola Lehners, Elena Ellert, Jing Xu, Jens Hillengass, Jonas Leichsenring, Albrecht Stenzinger, Har… , 04 Apr 2018. - 10 S.
In: Leukemia and lymphoma, ISSN 1029-2403. 59(2018), 11, Seite 2660-2669
DOI: 10.1080/10428194.2018.1443450
Hillengaß, Jens: Minimal residual disease in multiple myeloma : use of magnetic resonance imaging / Jens Hillengass, Maximilian Merz, Stefan Delorme, 12 February 2018. - 3 S.
In: Seminars in hematology, ISSN 1532-8686. 55(2018), 1, Seite 19-21
DOI: 10.1053/j.seminhematol.2018.02.001
Knodel, Markus M.: Virtual reality in advanced medical immersive imaging : a workflow for introducing virtual reality as a supporting tool in medical imaging / Markus M. Knodel, Babett Lemke, Michael Lampe, Michael Hoffer, Clarissa Gillmann, Michael Uder, Jens… , 27 February 2018. - 10 S.
In: Computing and visualization in science, ISSN 1433-0369. 18(2018), 6, Seite 203-212
DOI: 10.1007/s00791-018-0292-3
Kriegsmann, Katharina: Quantification of number of CD38 sites on bone marrow plasma cells in patients with light chain amyloidosis and smoldering multiple myeloma / Katharina Kriegsmann, Tobias Dittrich, Brigitte Neuber, Mohamed H. S. Awwad, Ute Hegenbart, Hartmut … , 25 March 2018. - 10 S.
In: Cytometry, ISSN 1552-4957. 94(2018), 5, Seite 767-776
DOI: 10.1002/cyto.b.21636
Maatouk, Imad: Multiples Myelom und seine Vorstufen / Imad Maatouk, Hartmut Goldschmidt, Jens Hillengass, [August 2018]. - 7 S.
In: Der Onkologe, ISSN 1433-0415. 24(2018), 8, Seite 625-631
DOI: 10.1007/s00761-018-0387-y
Brandelik, Simone Christine: Fokale Läsionen in der Ganzkörper-MRT beim multiplen Myelom : Quantifizierung der Tumorlast und Korrelation mit krankheitstypischen Parametern und Prognose / S.C. Brandelik, J. Krzykalla, T. Hielscher, J. Hillengass, J.K. Kloth, H.U. Kauczor, M.A. Weber, 2018. - 7 S.
In: Der Radiologe, ISSN 1432-2102. 58(2018), 1, Seite 72-78
DOI: 10.1007/s00117-017-0299-7
Went, Molly: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma / Molly Went, Amit Sud, Asta Försti, Britt-Marie Halvarsson, Niels Weinhold et al.#, 13 September 2018. - 10 S.
In: Nature Communications, ISSN 2041-1723. 9(2018) Artikel-Nummer 3707, 10 Seiten
DOI: 10.1038/s41467-018-04989-w
Goldschmidt, Hartmut: Bortezomib before and after high-dose therapy in myeloma : long-term results from the phase III HOVON-65/GMMG-HD4 trial / H. Goldschmidt, H.M Lokhorst, E.K. Mai, B. van der Holt, I.W. Blau, S. Zweegman, K.C. Weisel, E. Vel… , 2018. - 8 S.
In: Leukemia, ISSN 1476-5551. 32(2018), Seite 383-390
Maatouk, Imad: Association of resilience with health-related quality of life and depression in multiple myeloma and its precursors : results of a German cross-sectional study / Imad Maatouk, Susanne He, Natalia Becker, Manuela Hummel, Stefan Hemmer, Michaela Hillengass, Hartmu… , July 30, 2018. - 14 S.
In: BMJ open, ISSN 2044-6055. 8(2018,7) Artikel-Nummer e021376, 8 Seiten
DOI: 10.1136/bmjopen-2017-021376
Seckinger, Anja: CD38 as immunotherapeutic target in light chain amyloidosis and multiple myeloma : association with molecular entities, risk, survival, and mechanisms of upfront resistance / Anja Seckinger, Jens Hillengass, Martina Emde, Susanne Beck, Christoph Kimmich, Tobias Dittrich, Mic… , 20 July 2018. - 15$
In: Frontiers in immunology, ISSN 1664-3224. 9(2018), Artikel-ID 1676, Seite 1-15
DOI: 10.3389/fimmu.2018.01676
Giesen, Nicola: Analysis of long-term survival in multiple myeloma after first-line autologous stem cell transplantation : impact of clinical risk factors and sustained response / Nicola Lehners, Natalia Becker, Axel Benner, Maria Pritsch, Martin Löpprich, Elias Karl Mai, Jens Hi… , 2018. - 10 S.
In: Cancer medicine, ISSN 2045-7634. 7(2018), 2, Seite 307-316
DOI: 10.1002/cam4.1283
Mosebach, Jennifer: Prognostic significance of tumor burden assessed by whole-body magnetic resonance imaging in multiple myeloma patients treated with allogeneic stem cell transplantation / Jennifer Mosebach, Sofia Shah, Stefan Delorme, Thomas Hielscher, Hartmut Goldschmidt, Heinz-Peter Sc… , 2018. - 8 S.
In: Haematologica, ISSN 1592-8721. 103(2018), 2, Seite 336-343
DOI: 10.3324/haematol.2017.176073
Seckinger, Anja: Asymptomatic multiple myeloma : molecular background of progression and prognosis / Anja Seckinger, Anna Jauch, Martina Emde, Susanne Beck, Marcel Mohr, Martin Granzow, Thomas Hielsche… , February 2017. - 2 S.
In: Clinical lymphoma, myeloma & leukemia, ISSN 2152-2669. 17(2017), 1, Supplement vom: Feb., Seite e9-e10
DOI: 10.1016/j.clml.2017.03.016
Went, Molly: Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach : letter to the editor / M. Went, A. Sud, P.J. Law, D.C. Johnson, N. Weinhold, A. Försti, M. van Duin, J.S. Mitchell, B. Chen… , 16 June 2017. - 3 S.
In: Blood cancer journal, ISSN 2044-5385. 7(2017), 6, Artikel-ID e573, Seite 1-3
DOI: 10.1038/bcj.2017.48
Kumar, Shaji: Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors : a multicenter IMWG study / S.K. Kumar, M. A. Dimopoulos, E. Kastritis, E. Terpos, H. Nahi, H. Goldschmidt, J. Hillengass, X. Le… , November 2017. - 6 S.
In: Leukemia, ISSN 1476-5551. 31(2017), 11, Seite 2443-2448
DOI: 10.1038/leu.2017.138
Kriegsmann, Katharina: Potential therapeutic targets in plasma cell disorders : a flow cytometry study / Katharina Lisenko, Stefan Schönland, Ute Hegenbart, Katrin Wallenwein, Ute Braun, Elias K. Mai, Jens… , 2017. - 8 S.
In: Cytometry, ISSN 1552-4957. 92(2017), 2, Seite 145-152
DOI: 10.1002/cyto.b.21351
Kriegsmann, Katharina: Storage duration of autologous stem cell preparations has no impact on hematopoietic recovery after transplantation / Katharina Lisenko, Petra Pavel, Mark Kriegsmann, Thomas Bruckner, Jens Hillengass, Hartmut Goldschmi… , 2017. - 7 S.
In: Biology of blood and marrow transplantation, ISSN 1523-6536. 23(2017), 4, Seite 684-690
DOI: 10.1016/j.bbmt.2016.12.631
Merz, Maximilian: Meeting report of the 6th Heidelberg Myeloma Workshop : current status and developments in diagnosis and therapy of multiple myeloma / Maximilian Merz, Marc S. Raab, Hartmut Goldschmidt, Jens Hillengass. - 6 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 143(2017), 12, S. 2521-2526
DOI: 10.1007/s00432-017-2463-x
Merz, Maximilian: Longitudinal fluorescence in situ hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation / Maximilian Merz, Anna Jauch, Thomas Hielscher, Elias K. Mai, Anja Seckinger, Dirk Hose, Uta Bertsch,… , May 11, 2017. - 7 S.
In: Haematologica, ISSN 1592-8721. 102(2017), 8, Seite 1432-1438
DOI: 10.3324/haematol.2017.168005
Kriegsmann, Katharina: Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myeloma / Katharina Lisenko, Marc-Andrea Baertsch, Renate Meiser, Petra Pavel, Thomas Bruckner, Mark Kriegsman… , October 2017. - 7 S.
In: Transfusion, ISSN 1537-2995. 57(2017), 10, Seite 2359-2365
DOI: 10.1111/trf.14211
Bärtsch, Marc-Andrea: Therapeutic monoclonal antibodies in combination with pomalidomide can overcome refractoriness to both agents in multiple myeloma : a case-based approach / Marc-Andrea Baertsch, Michael Hundemer, Jens Hillengass, Hartmut Goldschmidt, Marc S. Raab. - 4 S.
In: Hematological oncology, ISSN 1099-1069. 36(2018), 1, S. 258-261
DOI: 10.1002/hon.2473
Bärtsch, Marc-Andrea: Efficacy and tolerability of the histone deacetylase inhibitor panobinostat in clinical practice / Marc-Andrea Baertsch, Jens Hillengass, Joanna Blocka, Stefan Schönland, Ute Hegenbart, Hartmut Golds… . - 7 S.
In: Hematological oncology, ISSN 1099-1069. 36(2018), 1, S. 210-216
DOI: 10.1002/hon.2462
Hillengaß, Jens: Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma : a study of the International Myeloma Working Group / J. Hillengass, L.A. Moulopoulos, S. Delorme, V. Koutoulidis, J. Mosebach, T. Hielscher, M. Drake, S.… , 2017. - 6 S.
In: Blood cancer journal, ISSN 2044-5385. 7(2017), Issue 8, Artikelnummer e599, 6 Seiten
DOI: 10.1038/bcj.2017.78
Seckinger, Anja: Target expression, generation, preclinical activity, and pharmacokinetics of the BCMA-T cell bispecific antibody EM801 for multiple myeloma treatment / Anja Seckinger, Jose Antonio Delgado, Samuel Moser, Laura Moreno, Brigitte Neuber, Anna Grab, Susann… , 2017. - 15 S.
In: Cancer cell, ISSN 1878-3686. 31(2017), 3, Seite 396-410
DOI: 10.1016/j.ccell.2017.02.002
Groß, Jonathan P.: Body fat composition as predictive factor for treatment response in patients with newly diagnosed multiple myeloma : subgroup analysis of the prospective GMMG MM5 trial / Jonathan P. Groß, Johanna Nattenmüller, Stefan Hemmer, Diana Tichy, Julia Krzykalla, Hartmut Goldsch… , July 25, 2017. - 12 S.
In: OncoTarget, ISSN 1949-2553. 8(2017), 40, Seite 68460-68471
DOI: 10.18632/oncotarget.19536
Cavo, Michele: Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders : a consensus statement by the International Myeloma Working Group / Michele Cavo, Evangelos Terpos, Cristina Nanni, Philippe Moreau, Suzanne Lentzsch, Sonja Zweegman, J… . - 12 S.
In: The lancet, ISSN 1474-5488. 18(2017), 4, S. e206-e217
DOI: 10.1016/S1470-2045(17)30189-4
Kriegsmann, Katharina: High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting / Katharina Lisenko, Sandra Sauer, Thomas Bruckner, Gerlinde Egerer, Hartmut Goldschmidt, Jens Hilleng… , 22 February 2017. - 10 S.
In: BMC cancer, ISSN 1471-2407. 17(2017) Artikel-Nummer 151, 10 Seiten
DOI: 10.1186/s12885-017-3137-4
Kriegsmann, Katharina: High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting / Katharina Lisenko, Sandra Sauer, Thomas Bruckner, Gerlinde Egerer, Hartmut Goldschmidt, Jens Hilleng… . -
London; Berlin; Heidelberg: BioMed Central; Springer, 2017. - 1 Online-Ressource (10 Seiten)
DOI: 10.1186/s12885-017-3137-4
Seckinger, Anja: Asymptomatic multiple myeloma : background of progression, evolution, and prognosis / Anja Seckinger, MD, Anna Jauch, PhD, Martina Emde, Susanne Beck, Marcel Mohr, Martin Granzow, PhD, … , 2 December 2016. - 3 S.
In: Blood, ISSN 1528-0020. 128(2016), 22, Artikel-ID 235, Seite 1-3
DOI: 10.1182/blood.V128.22.235.235
Krämer, Isabelle: Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitro / Isabelle Krämer, Melanie Engelhardt, Sabrina Fichtner, Brigitte Neuber, Sergej Medenhoff, Uta Bertsc… , 31 May 2016. - 10 S.
In: OncoImmunology, ISSN 2162-402X. 5(2016,5) Artikel-Nummer e1139662, 10 seiten
DOI: 10.1080/2162402X.2016.1139662
Johnson, David C.: Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma / David C. Johnson, Niels Weinhold, Jonathan S. Mitchell, Bowang Chen, Martin Kaiser, Dil B. Begum, Je… , 8 Jan 2016. - 7 S.
In: Nature Communications, ISSN 2041-1723. 7(2016), Artikel-ID 10290, Seite 1-7
DOI: 10.1038/ncomms10290
Weinhold, Niels: Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma / Niels Weinhold, Desiree Kirn, Anja Seckinger, Thomas Hielscher, Martin Granzow, Uta Bertsch, Gerlind… , March 2016. - 4 S.
In: Haematologica, ISSN 1592-8721. 101(2016), 3, Seite e116-e119
DOI: 10.3324/haematol.2015.136929
Johnson, David C.: Genetic factors influencing the risk of multiple myeloma bone disease / DC Johnson, N Weinhold, J Mitchell, B Chen, OW Stephens, A Försti, J Nickel, M Kaiser, WA Gregory, D… , 12 January 2016. - 6 S.
In: Leukemia, ISSN 1476-5551. 30(2016), 4, Seite 883-888
DOI: 10.1038/leu.2015.342
Mai, Elias K.: Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma : long-term results from the phase III GMMG-HD2 trial / Elias K. Mai, Axel Benner, Uta Bertsch, Peter Brossart, Annette Hänel, Volker Kunzmann, Ralph Nauman… , 17 March 2016. - 11 S.
In: British journal of haematology, ISSN 1365-2141. 173(2016), 5, Seite 731-741
DOI: 10.1111/bjh.13994
Bärtsch, Marc-Andrea: Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE : a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma / Marc-Andrea Baertsch, Jana Schlenzka, Elias K. Mai, Maximilian Merz, Jens Hillengaß, Marc S. Raab, D… , 25 April 2016. - 10 S.
In: BMC cancer, ISSN 1471-2407. 16(2016) Artikel-Nummer 290, 10 Seiten
DOI: 10.1186/s12885-016-2321-2
Hillengaß, Jens: Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myeloma / Jens Hillengass, Judith Ritsch, Maximilian Merz, Barbara Wagner, Christina Kunz, Thomas Hielscher, H… , 15 March 2016. - 9 S.
In: British journal of haematology, ISSN 1365-2141. 174(2016), 1, Seite 127-135
DOI: 10.1111/bjh.14038
Sonneveld, Pieter: Treatment of multiple myeloma with high-risk cytogenetics : a consensus of the International Myeloma Working Group / Pieter Sonneveld, Hervé Avet-Loiseau, Sagar Lonial, Saad Usmani, David Siegel, Kenneth C. Anderson, … , March 21, 2016. - 8 S.
In: Blood, ISSN 1528-0020. 127(2016), 24, Seite 2955-2962
DOI: 10.1182/blood-2016-01-631200
Kumar, Shaji: International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma / Shaji Kumar, Bruno Paiva, Kenneth C Anderson, Brian Durie, Ola Landgren, Philippe Moreau, Nikhil Mun… . - 19 S.
In: The lancet, ISSN 1474-5488. 17(2016), 8, S. e328-e346
DOI: 10.1016/S1470-2045(16)30206-6
Wuchter, Patrick: Performance assessment and benchmarking of autologous peripheral blood stem cell collection with two different apheresis devices / P. Wuchter, M. Hundemer, A. Schmitt, M. Witzens‐Harig, P. Pavel, J. Hillengass, H. Goldschmidt, A.D.… , 2017. - 7 S.
In: Transfusion medicine, ISSN 1365-3148. 27(2017), 1, Seite 36-42
DOI: 10.1111/tme.12367
Musto, Pellegrino: Second primary malignancies in multiple myeloma : an overview and IMWG consensus / P. Musto, K.C. Anderson, M. Attal, P.G. Richardson, A. Badros, J. Hou, R. Comenzo, J. Du, B.G.M. Dur… , 2017. - 18 S.
In: Annals of oncology, ISSN 1569-8041. 28(2017), 2, Seite 228-245
DOI: 10.1093/annonc/mdw606
Sachpekidis, Christos: Treatment response evaluation with 18F-FDG PET/CT and 18F-NaF PET/CT in multiple myeloma patients undergoing high-dose chemotherapy and autologous stem cell transplantation / Christos Sachpekidis, J. Hillengass, H. Goldschmidt, B. Wagner, U. Haberkorn, K. Kopka, A. Dimitrako… , January 2017. - 13 S.
In: European journal of nuclear medicine and molecular imaging, ISSN 1619-7089. 44(2017), 1, Seite 50-62
DOI: 10.1007/s00259-016-3502-6
Mitchell, Jonathan S.: Genome-wide association study identifies multiple susceptibility loci for multiple myeloma / Jonathan S. Mitchell, Ni Li, Niels Weinhold, Asta Försti, Mina Ali, Mark van Duin, Gudmar Thorleifss… , 1 Jul 2016. - 9 S.
In: Nature Communications, ISSN 2041-1723. 7(2016), Artikel-ID 12050, Seite 1-9
DOI: 10.1038/ncomms12050
Kortüm, Klaus Martin: Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes / K. Martin Kortüm, Elias K. Mai, Nur H. Hanafiah, Chang-Xi Shi, Yuan-Xiao Zhu, Laura Bruins, Santiago… , 25 July 2016. - 8 S.
In: Blood, ISSN 1528-0020. 128(2016), 9, Seite 1226-1233
DOI: 10.1182/blood-2016-02-698092
Mai, Elias K.: Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma : analyzing surrogates of tumour mass and biology / Elias K. Mai, Thomas Hielscher, Jost K. Kloth, Maximilian Merz, Sofia Shah, Michaela Hillengass, Bar… , 15 January 2016. - 10 S.
In: European radiology, ISSN 1432-1084. 26(2016), 11, Seite 3939-3948
DOI: 10.1007/s00330-015-4195-0
Breitkreutz, Iris: Dose-intensified bendamustine followed by autologous peripheral blood stem cell support in relapsed and refractory multiple myeloma with impaired bone marrow function / Iris Breitkreutz, Natalia Becker, Axel. Benner, Florentina Kosely, Christoph Heining, Jens Hillengas… , 2016. - 8 S.
In: Hematological oncology, ISSN 1099-1069. 34(2016), 4, Seite 200-207
DOI: 10.1002/hon.2199
Merz, Maximilian: Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial / Maximilian Merz, Hans Salwender, Mathias Haenel, Elias K. Mai, Uta Bertsch, Christina Kunz, Thomas H… , December 2016. - 3 S.
In: Haematologica, ISSN 1592-8721. 101(2016), 12, Seite e485-e487
DOI: 10.3324/haematol.2016.151266
Merz, Maximilian: Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myeloma / Maximilian Merz, Thomas Hielscher, Anja Seckinger, Dirk Hose, Elias K. Mai, Marc S. Raab, Hartmut Go… , 10 August 2016. - 5 S.
In: American journal of hematology, ISSN 1096-8652. 91(2016), 11, Seite E473-E477
DOI: 10.1002/ajh.24533
Merz, Maximilian: Survival of elderly patients with multiple myeloma : effect of upfront autologous stem cell transplantation / Maximilian Merz, Lina Jansen, Felipe A. Castro, Jens Hillengass, Hans Salwender, Katja Weisel, Chris… , July 2016. - 8 S.
In: European journal of cancer, ISSN 1879-2995. 62(2016), Seite 1-8
DOI: 10.1016/j.ejca.2016.04.004
Bärtsch, Marc-Andrea: Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE : a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma / Marc-Andrea Bärtsch, Jana Schlenzka, Elias Karl Mai, Maximilian Merz, Jens Hillengaß, Marc S. Raab, … . -
London; Berlin; Heidelberg: BioMed Central; Springer, 2016. - 1 Online-Ressource (10 Seiten)
Campa, Daniele: Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length / Daniele Campa, Alessandro Martino, Judit Varkonyi, Fabienne Lesueur, Krzysztof Jamroziak, Stefano La… , 2015. - 8 S.
In: International journal of cancer, ISSN 1097-0215. 136(2015), 5, Seite E351-E358
DOI: 10.1002/ijc.29101
Zamagni, Elena: 18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease / E. Zamagni, C. Nanni, F. Gay, A. Pezzi, F. Patriarca, M. Bellò, I. Rambaldi, P. Tacchetti, J. Hillen… , 2016. - 6 S.
In: Leukemia, ISSN 1476-5551. 30(2016), 2, Seite 417-422
DOI: 10.1038/leu.2015.291
Giralt, Sergio: American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on salvage hematopoietic cell transplantation in patients with relapsed multiple myeloma / Sergio Giralt, Laurent Garderet, Brian Durie, Gordon Cook, Gosta Gahrton, Benedetto Bruno, Paremeswe… , 30 September 2015. - 13 S.
In: Biology of blood and marrow transplantation, ISSN 1523-6536. 21(2015), 12, Seite 2039-2051
DOI: 10.1016/j.bbmt.2015.09.016
Merz, Maximilian: Meeting report of the 5th Heidelberg Myeloma Workshop : current status and developments in diagnosis and therapy of multiple myeloma / Maximilian Merz, Jens Hillengass & Hartmut Goldschmidt, 2016. - 5 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 142(2016), 1, Seite 247-251
DOI: 10.1007/s00432-015-1993-3
Merz, Maximilian: Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma : results of a prospective DCE-MRI study / Maximilian Merz, Thomas M. Moehler, Judith Ritsch, Tobias Bäuerle, Christian M. Zechmann, Barbara Wa… , 2016. - 8 S.
In: European radiology, ISSN 1432-1084. 26(2016), 5, Seite 1404-1411
DOI: 10.1007/s00330-015-3928-4
Dimopoulos, Meletios A.: Role of magnetic resonance imaging in the management of patients with multiple myeloma : a consensus statement / Meletios A. Dimopoulos, Jens Hillengass, Saad Usmani, Elena Zamagni, Suzanne Lentzsch, Faith E. Davi… . - 8 S.
In: Journal of clinical oncology, ISSN 1527-7755. 33(2015), 6, S. 657-664
DOI: 10.1200/JCO.2014.57.9961
Sachpekidis, Christos: 18F-FDG dynamic PET/CT in patients with multiple myeloma : Patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate / Christos Sachpekidis, MD, Elias K. Mai, MD, Hartmut Goldschmidt, MD, Jens Hillengass, MD, Dirk Hose,… , January 23, 2015. - 8 S.
In: Clinical nuclear medicine, ISSN 1536-0229. 40(2015), 6, Seite e300-e307
DOI: 10.1097/RLU.0000000000000773
Mai, Elias K.: A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma / Elias K. Mai, Thomas Hielscher, Jost K. Kloth, Maximilian Merz, Sofia Shah, Marc S. Raab, Michaela H… , June 2015. - 8 S.
In: Haematologica, ISSN 1592-8721. 100(2015), 6, Seite 818-825
DOI: 10.3324/haematol.2015.124115
Merz, Maximilian: Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma : an interim analysis from the prospective GMMG-MM5 trial / Maximilian Merz, Hans Salwender, Mathias Haenel, Elias K. Mai, Uta Bertsch, Christina Kunz, Thomas H… , July 2015. - 6 S.
In: Haematologica, ISSN 1592-8721. 100(2015), 7, Seite 964-969
DOI: 10.3324/haematol.2015.124347
Merz, Maximilian: Extramedullary relapse after accidental head injury in a patient with multiple myeloma / Maximilian Merz, Leonille Schweizer, Modar Kentar, Till Schneider, Hartmut Goldschmidt, Jens Hilleng… , 2015. - 3 S.
In: Annals of hematology, ISSN 1432-0584. 94(2015), 2, Seite 351-353
DOI: 10.1007/s00277-014-2147-4
Merz, Maximilian: Dynamic contrast-enhanced magnetic resonance imaging for assessment of antiangiogenic treatment effects in multiple myeloma / Maximilian Merz, Judith Ritsch, Christina Kunz, Barbara Wagner, Sandra Sauer, Dirk Hose, Thomas Moeh… , 1 January 2015. - 7 S.
In: Clinical cancer research, ISSN 1557-3265. 21(2015), 1, Seite 106-112
DOI: 10.1158/1078-0432.CCR-14-1029
Seckinger, Anja: miRNAs in multiple myeloma : a survival relevant complex regulator of gene expression / Anja Seckinger, Tobias Meißner, Jérôme Moreaux, Vladimir Benes, Jens Hillengass, Mirco Castoldi, Jür… , 17 November 2015. - 19 S.
In: OncoTarget, ISSN 1949-2553. 6(2015), 36, Seite 39165-39183
DOI: 10.18632/oncotarget.5381
Mai, Elias K.: Phase III trial of bortezomib, cyclophosphamide, dexamethasone (VCD) versus bortezomib, doxorubicin, dexamethasone (PAd) in newly-diagnosed myeloma / E. K. Mai, U. Bertsch, J. Dürig, C. Kunz, M. Haenel, I. W. Blau, M. Munder, A. Jauch, B. Schurich, T… , 2015
In: Leukemia, ISSN 1476-5551. 29(2015), 8, Seite 1721-1729
DOI: 10.1038/leu.2015.80
Caers, Jo: The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow up of multiple myeloma / Jo Caers, Nadia Withofs, Jens Hillengass, Paolo Simoni, Elena Zamagni, Roland Hustinx, and Yves Begu… , 2014-04-01. - 9 S.
In: Haematologica, ISSN 1592-8721. 99(2014), 4, Seite 629-637
DOI: 10.3324/haematol.2013.091918
Rajkumar, S. Vincent: International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma / S. Vincent Rajkumar, Meletios A. Dimopoulos, Antonio Palumbo, Joan Blade, Giampaolo Merlini, María-V… , 26 October 2014. - 11 S.
In: The lancet, ISSN 1474-5488. 15(2014), 12, Seite e538-e548
DOI: 10.1016/S1470-2045(14)70442-5
Bretschi, Maren: Assessing treatment response of osteolytic lesions by manual volumetry, automatic segmentation, and RECIST in experimental bone metastases / Maren Bretschi, Andrea Fränzle, Maximilian Merz, Jens Hillengass, Wolfhard Semmler, Rolf Bendl, Tobi… , [September 2014]. - 8 S.
In: Academic radiology, ISSN 1878-4046. 21(2014), 9, Seite 1177-1184
DOI: 10.1016/j.acra.2014.04.011
Merz, Maximilian: Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma / M. Merz, T. Hielscher, B. Wagner, S. Sauer, S. Shah, M. S. Raab, A. Jauch, K. Neben, D. Hose, G. Ege… , [2014]. - 7 S.
In: Leukemia, ISSN 1476-5551. 28(2014), 9, Seite 1902-1908
DOI: 10.1038/leu.2014.75
Hillengaß, Jens: The application of Gadopentate-Dimeneglumin has no impact on progression free and overall survival as well as renal function in patients with monoclonal plasma cell disorders if general precautions are taken / J. Hillengass, J. Stoll, C.M. Zechmann, C. Kunz, B. Wagner, C. Heiss, M. Sumkauskaite, T.M. Moehler,… , 2015. - 6 S.
In: European radiology, ISSN 1432-1084. 25(2015), 3, Seite 745-750
DOI: 10.1007/s00330-014-3458-5
Andrulis, Mindaugas: Infiltration patterns in monoclonal plasma cell disorders : correlation of magnetic resonance imaging with matched bone marrow histology / Mindaugas Andrulis, Tobias Bäuerle, Hartmut Goldschmidt, Stefan Delorme, Ola Landgren, Peter Schirma… , 22 March 2014. - 5 S.
In: European journal of radiology, ISSN 1872-7727. 83(2014), 6, Seite 970-974
DOI: 10.1016/j.ejrad.2014.03.005
Cheng, Jian: Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myeloma / Jian Cheng, Michael Schmitt, Patrick Wuchter, Eike C. Buss, Mathias Witzens-Harig, Kai Neben, Michae… , 2015. - 9 S.
In: Transfusion, ISSN 1537-2995. 55(2015), 2, Seite 275-283
DOI: 10.1111/trf.12813
Delorme, Stefan: Multiples Myelom : Einführung zum Thema / S. Delorme, J. Hillengaß. - 2 S.
In: Der Radiologe, ISSN 1432-2102. 54(2014), 6, S. 536-537
DOI: 10.1007/s00117-013-2624-0
Wolf, Maya Barbara: Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolyses in patients with monoclonal plasma cell disease / Maya B. Wolf, Fritz Murray, Kerstin Kilk, Jens Hillengass, Stefan Delorme, Christiane Heiss, Kai Neb… , July 2014. - 9 S.
In: European journal of radiology, ISSN 1872-7727. 83(2014), 7, Seite 1222-1230
DOI: 10.1016/j.ejard.2014.02.008
Kloth, Jost: Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity / Jost K. Kloth, Jens Hillengass, Karin Listl, Kerstin Kilk, Thomas Hielscher, Ola Landgren, Stefan De… , 2014. - 7 S.
In: International journal of cancer, ISSN 1097-0215. 135(2014), 10, Seite 2380-2386
DOI: 10.1002/ijc.28877
Pianko, Matthew J.: Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease / Matthew J. Pianko, Evangelos Terpos, G. David Roodman, Chaitanya R. Divgi, Sonja Zweegman, Jens Hill… . - 10 S.
In: Clinical cancer research, ISSN 1557-3265. 20(2014), 23, S. 5888-5897
DOI: 10.1158/1078-0432.CCR-14-1692
Sauer, Sandra: Impact of radiation therapy on stem cell harvest in multiple myeloma / Sandra Sauer, Andreas Marco Fischer, Andrea Fraenzle, Christina Kunz, Maximilian Merz, Patrick Wucht… , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 5822, 1 S.
DOI: 10.1182/blood.V124.21.5822.5822
Hájek, Roman: Prediction of progression of smouldering into therapy requiring multiple myeloma by easily accessible clinical factors [in 527 patients] / Roman Hajek, Viera Sandecka, Anja Seckinger, Ivan Spicka, Vlastimil Scudla, Evzen Gregora, Jakub Rad… , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 2071, 1 S.
Hillengaß, Jens: Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance / J. Hillengass, M.-A. Weber, K. Kilk, K. Listl, B. Wagner-Gund, M. Hillengass, T. Hielscher, A. Farid… , 2014. - 5 S.
In: Leukemia, ISSN 1476-5551. 28(2014), 1, Seite 174-178
DOI: 10.1038/leu.2013.244
Merz, Maximilian: Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents / Merz, M.; Neben, K.; Raab, M. S.; Sauer, S.; Egerer, G.; Hundemer, M.; Hose, D.; Kunz, C.; Heiss, C.… , 2014. - 7 S.
In: Annals of oncology, ISSN 1569-8041. 25(2014), 1, Seite 189-195
DOI: 10.1093/annonc/mdt509
Neben, Kai: Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load / Kai Neben, Anna Jauch, Thomas Hielscher, Jens Hillengass, Nicola Lehners, Anja Seckinger, Martin Gra… , October 21, 2013. - 9 S.
In: Journal of clinical oncology, ISSN 1527-7755. 31(2013), 34, Seite 4325-4332
DOI: 10.1200/JCO.2012.48.4923
Shah, Rajiv: Intravoxel incoherent motion imaging for assessment of bone marrow infiltration of monoclonal plasma cell diseases / Rajiv Shah, Bram Stieltjes, Mindaugas Andrulis, Ruth Pfeiffer, Migle Sumkauskaite, Stefan Delorme, H… , 17 May 2013. - 5 S.
In: Annals of hematology, ISSN 1432-0584. 92(2013), 11, Seite 1553-1557
DOI: 10.1007/s00277-013-1786-1
Sellner, Leopold: Autologous retransplantation for patients with recurrent multiple myeloma : a single-center experience with 200 patients / Leopold Sellner, Christiane Heiss, Axel Benner, Marc S. Raab, Jens Hillengass, Dirk Hose, Nicola Leh… , April 10, 2013. - 9 S.
In: Cancer, ISSN 1097-0142. 119(2013), 13, Seite 2438-2446
DOI: 10.1002/cncr.28104
Schmitt, Stefan: Bisphosphonate treatment and renal function in 201 myeloma patients undergoing stem cell transplantation / S. Schmitt, T. Hielscher, C. Baldus, K. Neben, G. Egerer, J. Hillengaß, M. Raab, D. Hose, A.D. Ho, R… , 25 April 2013. - 8 S.
In: International journal of hematology, ISSN 1865-3774. 97(2013), 6, Seite 765-772
DOI: 10.1007/s12185-013-1320-1
Hillengaß, Jens: Meeting report of the 4th Heidelberg Myeloma Workshop : Current status and developments in diagnosis and therapy of multiple myeloma / Jens Hillengass, Merz Maximilian, Hartmut Goldschmidt, 18 July 2013. - 5 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 139(2013), 11, Seite 1807-1811
DOI: 10.1007/s00432-013-1468-3
Hillengaß, Jens: Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders : imaging “early myeloma” / Jens Hillengass, Ola Landgren, 28 Jan 2013. - 9 S.
In: Leukemia and lymphoma, ISSN 1029-2403. 54(2013), 7, Seite 1355-1363
DOI: 10.3109/10428194.2012.740559
Liu, Yifei: Quantitative assessment of microcirculation and diffusion in the bone marrow of osteoporotic rats using VCT, DCE-MRI, DW-MRI, and histology / Yifei Liu, Liji Cao, Jens Hillengass, Stefan Delorme, Gudrun Schlewitz, Parameswari Govindarajan, Re… , March 1, 2013. - 9 S.
In: Acta radiologica, ISSN 1600-0455. 54(2013), 2, Seite 205-213
DOI: 10.1258/ar.2012.120508
Fränzle, Andrea: A quantification strategy for missing bone mass in case of osteolytic bone lesions / Andrea Fränzle, Maren Bretschi and Tobias Bäuerle, Kristina Giske, Jens Hillengass, Rolf Bendl, 11 November 2013. - 8 S.
In: Medical physics, ISSN 2473-4209. 40(2013), 12, Artikel-ID 123501, Seite 123501-1-123501-8
DOI: 10.1118/1.4828843
Lamers, Jette: Psychosocial support in patients with multiple myeloma at time of diagnosis : who wants what / Jette Lamers; Mechthild Hartmann; Hartmut Goldschmidt; Anette Brechtel; Jens Hillengass and Wolfgan… , 2013. - 8 S.
In: Psycho-oncology, ISSN 1099-1611. 22(2013), 10, Seite 2313-2320
DOI: 10.1002/pon.3284
Hillengaß, Jens: Prognostische und pathophysiologische Bedeutung serologischer, zytogenetischer und MRT-basierter Messgrößen bei monoklonalen Plasmazellerkrankungen / vorgelegt von Jens Hillengaß, 2013. - Getr. Zählung : Ill., graph. Darst.
McClanahan, Fabienne: Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma / F. McClanahan, T. Hielscher, M. Rieger, M. Hensel, M. Bentz, I. Schmidt‐Wolf, A. Käbisch, H. Salwend… , October 2012. - 9 S.
In: American journal of hematology, ISSN 1096-8652. 87(2012), 10, Seite E68-E71
DOI: 10.1002/ajh.23286
Kropff, Martin: Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma : results from OPTIMUM, a randomized trial / Martin Kropff, Honorata Giongco Baylon, Jens Hillengass, Tadeusz Robak, Roman Hajek, Peter Liebisch,… , 2012. - 8 S.
In: Haematologica, the hematology journal, ISSN 1592-8721. 97(2012), 5, Seite 784-791
DOI: 10.3324/haematol.2011.044271
Hillengaß, Jens: Multiples Myelom : aktuelle Empfehlungen für die Bildgebung / J. Hillengass, S. Delorme. - 6 S.
In: Der Radiologe, ISSN 1432-2102. 52(2012), 4, S. 360-365
DOI: 10.1007/s00117-011-2257-0
Seckinger, Anja: Clinical and prognostic role of annexin A2 in multiple myeloma. / Anja Seckinger, Tobias Meiβner, Jérôme Moreaux, Daniela Depeweg, Jens Hillengass, Katja Hose, Thierr… . - 8 S.
In: Blood, ISSN 1528-0020. 120(2012), 5, S. 1087-94
DOI: 10.1182/blood-2012-03-415588
Hillengaß, Jens: Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma / Jens Hillengass, Sofia Ayyaz, Kerstin Kilk, Marc-André Weber, Thomas Hielscher, Rajiv Shah, Dirk Hos… , 2012. - 4 S.
In: Haematologica, the hematology journal, ISSN 1592-8721. 97(2012), 11, Seite 1757-1760
DOI: 10.3324/haematol.2012.065359
Hillengaß, Jens: Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging of bone marrow in healthy individuals / Jens Hillengass, Bram Stieltjes, Tobias Bäuerle, Fabienne McClanahan, Christiane Heiss, Thomas Hiels… , April 1, 2011. - 7 S.
In: Acta radiologica, ISSN 1600-0455. 52(2011), 3 vom: Apr., Seite 324-330
DOI: 10.1258/ar.2010.100366
Klein, Ulrike: Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone / Ulrike Klein, Anna Jauch, Thomas Hielscher, Jens Hillengass, Marc S. Raab, Anja Seckinger, Dirk Hose… , 2011. - 9 S.
In: Cancer, ISSN 1097-0142. 117(2011), 10, Seite 2136-2144
DOI: 10.1002/cncr.25775
Krause, Sonja: Radiotherapy of solitary plasmacytoma / Sonja Krause, Jens Hillengass, Hartmut Goldschmidt, Jürgen Debus, Dirk Neuhof, 19 February 2011. - 5 S.
In: Annals of hematology, ISSN 1432-0584. 90(2011), 9, Seite 1093-1097
DOI: 10.1007/s00277-011-1190-7
Hose, Dirk: Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma / Dirk Hose, Thierry Rème, Thomas Hielscher, Jérôme Moreaux, Tobias Messner, Anja Seckinger, Axel Benn… , January, 2011. - 9 S.
In: Haematologica, the hematology journal, ISSN 1592-8721. 96(2011), 1, Seite 87-95
DOI: 10.3324/haematol.2010.030296
Kasperk, Christian: Kyphoplasty in patients with multiple myeloma a retrospective comparative pilot study / Christian Kasperk, Andreas Haas, Jens Hillengass, Christel Weiss, Kai Neben, Hartmut Goldschmidt, Ul… , 2012. - 8 S.
In: Journal of surgical oncology, ISSN 1096-9098. 105(2012), 7, Seite 679-686
DOI: 10.1002/jso.22101
Zechmann, Christian: Parametric histogram analysis of dynamic contrast-enhanced MRI in multiple myeloma : a technique to evaluate angiogenic response to therapy? / Christian M. Zechmann, Lisa Traine, Tobias Meißner, Barbara Wagner-Gund, Frederik L. Giesel, Hartmut… . - 9 S.
In: Academic radiology, ISSN 1878-4046. 19(2012), 1, S. 100-108
DOI: 10.1016/j.acra.2011.09.007
Hillengaß, Jens: Meeting report of the third Heidelberg myeloma workshop : current status and developments in diagnosis and therapy of multiple myeloma / Jens Hillengaß, Kai Neben, Hartmut Goldschmidt, 2012. - 6 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 138(2012), 1, Seite 173-178
DOI: 10.1007/s00432-011-1071-4
Hillengaß, Jens: Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease : a comparative study with histology / Hillengass, J. ... Andrulis, M. ... Neben, K.; Ho, A. D. ... Goldschmidt, H. ..., 2011. - 8 S.
In: British journal of haematology, ISSN 0007-1048. 153(2011), 6, Seite 721-728
Hillengaß, Jens: Multiples Myelom : Epidemiologie und Stadieneinteilung / J. Hillengaß, H. Goldschmidt, 03 March 2010. - 7 S. : diagramme
In: Der Onkologe, ISSN 1433-0415. 16(2010), 3 vom: März, Seite 225-231
DOI: 10.1007/s00761-010-1792-z
McClanahan, Fabienne: Clinical outcome of patients with follicular lymphoma and bulky disease after Rituximab-CHOP immunochemotherapy with and without consolidating radiotherapy / Fabienne McClanahan, Thomas Hielscher, Michael Rieger, Manfred Hensel, Kai Neben, Jens Hillengass, K… , 15 June 2010. - 9 S.
In: European journal of haematology, ISSN 1600-0609. 85(2010), 1 vom: Juli, Seite 11-19
DOI: 10.1111/j.1600-0609.2010.01445.x
Fechtner, Kerstin: Staging Monoclonal Plasma Cell Disease : Comparison of the Durie-Salmon and the Durie-Salmon PLUS Staging Systems / Kerstin Fechtner, Jens Hillengass, Stefan Delorme, Christiane Heiss, Kai Neben, Hartmut Goldschmidt,… , Oct 2010. - 10 S.
In: Radiology, ISSN 1527-1315. 257(2010), 1, Seite 195-204
DOI: 10.1148/radiol.10091809
Hillengaß, Jens: Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma / Jens Hillengass, Kerstin Fechtner, Marc-André Weber, Tobias Bäuerle, Sofia Ayyaz, Christiane Heiss, … , [March 2010]. - 5 S. : 1 Diagramm
In: Journal of clinical oncology, ISSN 1527-7755. 28(2010), 9, Seite 1606-1610
DOI: 10.1200/JCO.2009.25.5356
Neben, Kai: Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation / Kai Neben, Anna Jauch, Uta Bertsch, Christiane Heiss, Thomas Hielscher, Anja Seckinger, Tina Mors, N… , 2010 Jul. - 8 S. : Diagramme
In: Haematologica, the hematology journal, ISSN 1592-8721. 95(2010), 7, Seite 1150-1157
DOI: 10.3324/haematol.2009.016436
Klein, Ulrike: Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasone / Ulrike Klein, Florentina Kosely, Jens Hillengaß, Michael Hundemer, Stefan Schmitt, Kai Neben, Thomas… , 2009. - 5 S.
In: Annals of hematology, ISSN 1432-0584. 88(2009), 1, Seite 67-71
DOI: 10.1007/s00277-008-0561-1
Hose, Dirk: Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma / Dirk Hose, Thierry Rème, Tobias Meissner, Jérôme Moreaux, Anja Seckinger, Joe Lewis, Vladimir Benes,… , [April 30 2009]. - 10 S. : Illustrationen
In: Blood, ISSN 1528-0020. 113(2009), 18, Seite 4331-4340
DOI: 10.1182/blood-2008-09-178350
Hose, Dirk: Induction of angiogenesis by normal and malignant plasma cells / Dirk Hose, Jérôme Moreaux, Tobias Meissner, Anja Seckinger, Hartmut Goldschmidt, Axel Benner, Karène… , [2 July 2009]. - 16 S.
In: Blood, ISSN 1528-0020. 114(2009), 1, Seite 128-143
DOI: 10.1182/blood-2008-10-184226
Hillengaß, Jens: Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculation / Jens Hillengass, Christian Zechmann, Tobias Bäuerle, Barbara Wagner-Gund, Christiane Heiss, Axel Ben… , May 2009. - 8 S. : Illustrationen
In: Clinical cancer research, ISSN 1557-3265. 15(2009), 9, Seite 3118-3125
DOI: 10.1158/1078-0432.CCR-08-2310
Bäuerle, Tobias: Multiple myeloma and monoclonal gammopathy of undetermined significance : importance of whole-body versus spinal MR imaging / Tobias Bäuerle, MD, Jens Hillengass, MD, Kerstin Fechtner, MD, Christian M. Zechmann, MD, Lars Grena… , Aug 1 2009. - 9 S. : Illustrationen
In: Radiology, ISSN 1527-1315. 252(2009), 2, Seite 477-485
DOI: 10.1148/radiol.2522081756
Seckinger, Anja: Bone morphogenic protein 6 : a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis / A. Seckinger, T. Meißner, J. Moreaux, H. Goldschmidt, G. M. Fuhler, A. Benner, M. Hundemer, T. Rème,… , 31 August 2009. - 14 S.
In: Oncogene, ISSN 1476-5594. 28(2009), 44, Seite 3866-3879
DOI: 10.1038/onc.2009.257
Hillengaß, Jens: Current status and developments in diagnosis and therapy of multiple myeloma / Jens Hillengass, Kai Neben, Hartmut Goldschmidt, 18 September 2009. - 5 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 136(2009), 1, Seite 151-155
DOI: 10.1007/s00432-009-0676-3
Hillengaß, Jens: Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis / J. Hillengass, A. D. Ho, H. Goldschmidt, R. Waldherr, T. M. Moehler, 11 October 2008. - 3 S.
In: International journal of hematology, ISSN 1865-3774. 88(2008), 4, Seite 454-456
DOI: 10.1007/s12185-008-0177-1
Hillengaß, Jens: Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myeloma / Jens Hillengass, Christian M. Zechmann, Andreas Nadler, Dirk Hose, Friedrich W. Cremer, Anna Jauch, … , 19 March 2008. - 5 S. : Illustrationen
In: International journal of cancer, ISSN 1097-0215. 122(2008), 12, Seite 2871-2875
DOI: 10.1002/ijc.23455
Hillengaß, Jens: Bildgebende Verfahren beim multiplen Myelom / J. Hillengaß, J. Hansmann, H. Goldschmidt, T.M. Möhler, 2007. - 6 S.
In: Krebsmedizin, ISSN 1868-4246. 16(2007), Seite 19-24
Hillengaß, Jens: Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma / Jens Hillengass, Klaus Wasser, Stefan Delorme, Fabian Kiessling, Christian Zechmann, Axel Benner, Ha… , [January 2007]. - 7 S. : Illustrationen
In: Clinical cancer research, ISSN 1557-3265. 13(2007), 2, Seite 475-481
DOI: 10.1158/1078-0432.CCR-06-0061
Möhler, Thomas: Thalidomide in multiple myeloma / T.M. Moehler, J. Hillengass, A. Glasmacher and H. Goldschmidt, [2006]. - 10 S.
In: Current pharmaceutical biotechnology, ISSN 1873-4316. 7(2006), 6, Seite 431-440
DOI: 10.2174/138920106779116919
Nosàs-Garcia, Sílvia: Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma : a comparative study with histology and clinical markers / Sílvia Nosàs-Garcia, Thomas Moehler, Klaus Wasser, Fabian Kiessling, Reiner Bartl, Ivan Zuna, Jens H… , 21 June 2005. - 7 S. : Illustrationen
In: Journal of magnetic resonance imaging, ISSN 1522-2586. 22(2005), 1 vom: Juni, Seite 154-162
DOI: 10.1002/jmri.20349
Wasser, Klaus: Dynamische MRT des Knochenmarks zum Monitoring des Multiplen Myeloms unter Thalidomid-Monotherapie oder Kombination mit CED-Chemotherapie / K. Wasser, T. Moehler, K. Neben, S. Nosas, J. Heiss, H. Goldschmidt, J. Hillengass, C. Düber, H. U. … , [2004]. - 11 S. : Illustrationen
In: RöFo, ISSN 1438-9010. 176(2004), 9, Seite 1285-1295
DOI: 10.1055/s-2004-813414
Möhler, Thomas: Antiangiogenic therapy in hematologic malignancies / T.M. Moehler, J. Hillengass, H. Goldschmidt, A.D. Ho, [2004]. - 14 S.
In: Current pharmaceutical design, ISSN 1873-4286. 10(2004), 11, Seite 1221-1234
Hillengaß, Jens: Charakterisierung der Angiogenese beim Multiplen Myelom : Angiogene Zytokine und Kontrast-verstärkte dynamische Magnetresonanztomographie / vorgelegt von Jens Hillengaß, 2003. - IV, 81 Bl. : Ill., graph. Darst.
Möhler, Thomas: Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging / Thomas M. Moehler, Hans Hawighorst, Kai Neben, Gerlinde Egerer, Jens Hillengass, Regina Max, Axel Be… , [15 September 2001]. - 7 S.
In: International journal of cancer, ISSN 1097-0215. 93(2001), 6 vom: Sept., Seite 862-868
DOI: 10.1002/ijc.1421
Neben, Kai: High plasma basic fibroblast growth factor concentration is associated with response to Thalidomide in progressive multiple myeloma / Kai Neben, Thomas Moehler, Gerlinde Egerer, Alwin Kraemer, Jens Hillengass, Axel Benner, Anthony D. … , [September 2001]. - 7 S.
In: Clinical cancer research, ISSN 1557-3265. 7(2001), 9, Seite 2675-2681
Möhler, Thomas: Funktionelle Magnetresonanztomographie in Diagnostik und Therapiemonitoring beim Multiplen Myelom / T.M. Moehler, H. Hawighorst, K. Neben, G. Egerer, A. Benner, J. Hillengass, R. Max, A.D. Ho, H. Gold… , [2000]. - 8 S.
In: Der Radiologe, ISSN 1432-2102. 40(2000), 8, Seite 723-730

IDs

GND:

124918549

Links

Hillengaß, Jens in ...

Export Publikationsliste

heiBIB

Bei fehlerhaften oder unvollständigen Angaben wenden Sie sich bitte an biblio@ub.uni-heidelberg.de.

Informationen zu heiBIB (inkl. Einbettung der Publikationslisten in eigene WWW-Seiten).

Impressum / Datenschutz Design